These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1380 related articles for article (PubMed ID: 24950615)

  • 1. Preparation and characterization of magnetic gold nanoparticles to be used as doxorubicin nanocarriers.
    Elbialy NS; Fathy MM; Khalil WM
    Phys Med; 2014 Nov; 30(7):843-8. PubMed ID: 24950615
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Doxorubicin loaded magnetic gold nanoparticles for in vivo targeted drug delivery.
    Elbialy NS; Fathy MM; Khalil WM
    Int J Pharm; 2015 Jul; 490(1-2):190-9. PubMed ID: 25997662
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multi-functional core-shell Fe
    S R; M P
    Colloids Surf B Biointerfaces; 2019 Feb; 174():252-259. PubMed ID: 30469046
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Magnetic/NIR-responsive drug carrier, multicolor cell imaging, and enhanced photothermal therapy of gold capped magnetite-fluorescent carbon hybrid nanoparticles.
    Wang H; Cao G; Gai Z; Hong K; Banerjee P; Zhou S
    Nanoscale; 2015 May; 7(17):7885-95. PubMed ID: 25854197
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thermal and pH responsive polymer-tethered multifunctional magnetic nanoparticles for targeted delivery of anticancer drug.
    Sahoo B; Devi KS; Banerjee R; Maiti TK; Pramanik P; Dhara D
    ACS Appl Mater Interfaces; 2013 May; 5(9):3884-93. PubMed ID: 23551195
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polylactide-based Magnetic Spheres as Efficient Carriers for Anticancer Drug Delivery.
    Mhlanga N; Sinha Ray S; Lemmer Y; Wesley-Smith J
    ACS Appl Mater Interfaces; 2015 Oct; 7(40):22692-701. PubMed ID: 26390359
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fabrication and spectroscopic studies of folic acid-conjugated Fe3O4@Au core-shell for targeted drug delivery application.
    Karamipour Sh; Sadjadi MS; Farhadyar N
    Spectrochim Acta A Mol Biomol Spectrosc; 2015 Sep; 148():146-55. PubMed ID: 25879984
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis of Cross-linked Poly (N-isopropylacrylamide) Magnetic Nano Composite for Application in the Controlled Release of Doxorubicin.
    Kaamyabi S; Badrian A; Akbarzadeh A
    Pharm Nanotechnol; 2017; 5(1):67-75. PubMed ID: 28948911
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Co-delivery of Doxorubicin and D-α-Tocopherol Polyethylene Glycol 1000 Succinate by Magnetic Nanoparticles.
    Metin E; Mutlu P; Gündüz U
    Anticancer Agents Med Chem; 2018; 18(8):1138-1147. PubMed ID: 29532763
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gold nanoparticles with a monolayer of doxorubicin-conjugated amphiphilic block copolymer for tumor-targeted drug delivery.
    Prabaharan M; Grailer JJ; Pilla S; Steeber DA; Gong S
    Biomaterials; 2009 Oct; 30(30):6065-75. PubMed ID: 19674777
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stimuli-responsive hybrid cluster bombs of PEGylated chitosan encapsulated DOX-loaded superparamagnetic nanoparticles enabling tumor-specific disassembly for on-demand drug delivery and enhanced MR imaging.
    Xie P; Du P; Li J; Liu P
    Carbohydr Polym; 2019 Feb; 205():377-384. PubMed ID: 30446118
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Doxorubicin-conjugated core-shell magnetite nanoparticles as dual-targeting carriers for anticancer drug delivery.
    Sadighian S; Rostamizadeh K; Hosseini-Monfared H; Hamidi M
    Colloids Surf B Biointerfaces; 2014 May; 117():406-13. PubMed ID: 24675279
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Folic acid conjugated Fe
    Rana S; Shetake NG; Barick KC; Pandey BN; Salunke HG; Hassan PA
    Dalton Trans; 2016 Nov; 45(43):17401-17408. PubMed ID: 27731450
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Poly(ethylene glycol)-modified PAMAM-Fe3O4-doxorubicin triads with the potential for improved therapeutic efficacy: generation-dependent increased drug loading and retention at neutral pH and increased release at acidic pH.
    Nigam S; Chandra S; Newgreen DF; Bahadur D; Chen Q
    Langmuir; 2014 Feb; 30(4):1004-11. PubMed ID: 24446987
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multi-functional nanocarriers based on iron oxide nanoparticles conjugated with doxorubicin, poly(ethylene glycol) and folic acid as theranostics for cancer therapy.
    Rajkumar S; Prabaharan M
    Colloids Surf B Biointerfaces; 2018 Oct; 170():529-537. PubMed ID: 29966906
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and in vitro and in vivo evaluations of poly(ethylene glycol)-block-poly(4-vinylbenzylphosphonate) magnetic nanoparticles containing doxorubicin as a potential targeted drug delivery system.
    Hałupka-Bryl M; Asai K; Thangavel S; Bednarowicz M; Krzyminiewski R; Nagasaki Y
    Colloids Surf B Biointerfaces; 2014 Jun; 118():140-7. PubMed ID: 24769390
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis of biocompatible nanocrystalline cellulose against folate receptors as a novel carrier for targeted delivery of doxorubicin.
    Karimian A; Yousefi B; Sadeghi F; Feizi F; Najafzadehvarzi H; Parsian H
    Chem Biol Interact; 2022 Jan; 351():109731. PubMed ID: 34728188
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    El-Ghareb WI; Swidan MM; Ibrahim IT; Abd El-Bary A; Tadros MI; Sakr TM
    Int J Pharm; 2020 Aug; 586():119514. PubMed ID: 32565281
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Preparation and in vitro evaluation of doxorubicin-loaded magnetic iron oxide nanoparticles].
    Shen S; Wu L; Wang CR; Qi XY; Ge YR; Jin Y
    Yao Xue Xue Bao; 2013 Dec; 48(12):1844-9. PubMed ID: 24689244
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Co-encapsulation of magnetic Fe
    Liang C; Li N; Cai Z; Liang R; Zheng X; Deng L; Feng L; Guo R; Wei B
    Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):4211-4221. PubMed ID: 31713444
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 69.